Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe
Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials
Directly to Patients
SOUTHBOROUGH, MA – September 30, 2020 – Veristat, a scientific-minded global clinical research organization (CRO), announced today the launch of a virtual clinical trial solution that is flexible and customizable so that patient interactions can be conducted at the clinical site, remotely at-home, or through a hybrid combination of both strategies.
Veristat Celebrates Its Support of over 75 Global Regulatory Submissions Since Its Founding
Veristat Partners with TRI to Provide Centralized and Risk-Based Monitoring Technology to Their Biopharmaceutical Clients
Expanding Its Clinical Operations and Biometrics Teams Dedicated to Emerging, Small and Mid-Sized Biopharma